trending Market Intelligence /marketintelligence/en/news-insights/trending/S8YdNjm-vJF3GgSwy7hokg2 content esgSubNav
In This List

Swedish biopharma Hansa Medical to change name

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Swedish biopharma Hansa Medical to change name

Hansa Medical AB (publ) will change its name to Hansa Biopharma AB.

Bolagsverket, also known as the Swedish Companies Registration Office, approved the name change.

The name change was approved by shareholders during the biopharmaceutical company's Dec. 4 extraordinary general meeting.

Lund, Sweden-based Hansa, which focuses on treatment and prevention of rare and severe autoimmune conditions and transplant rejection, said the name change will be implemented in the next days and weeks, and the company's ticker has changed to HNSA from HMED.